Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wenglitong capsules vs extended-release tolterodine for overactive bladder in Chinese women
ChiCTR-IPR-14005626Phase 3Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jan 2014
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in overactive bladder (OAB) comparing Wenglitong capsules monotherapy, Detrol LA monotherapy and Wenglitong capsules plus Detrol LA combination (3 arms). Started Jan 2014; status: completed.
02
Drugs
wenglitongtolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on ChiCTR-IPR-14005626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005626.